Contact

Our portfolio

SigmaScreening

SigmaScreening has developed a mammography device that reduces pain and improves diagnostic accuracy. Founded by Amsterdam UMC professors, the company aims to enhance breast cancer detection with their patented technology. SigmaScreening has licensed their technology to Teledyne, who continue development of the device.

  • Institute: Amsterdam UMC
Industry: Imaging, Medical Technology, Oncology
  • Founding year: 2010

Want to get in contact about SigmaScreening?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

AlpENa Biosciences
Developing bispecific antibodies as enhanced cancer immunotherapy.
Quantum Gateway Solutions
Providing quantum-safe security solutions to protect organizations from future cyber threats.
uniQure
Pioneering gene therapy, uniQure develops transformative treatments using its AAV-based technology platform.
AtMoves
Improving orthopedic diagnostics with advanced joint loading device and AI-based imaging technology.
AlpENa Biosciences
Developing bispecific antibodies as enhanced cancer immunotherapy.
Quantum Gateway Solutions
Providing quantum-safe security solutions to protect organizations from future cyber threats.
uniQure
Pioneering gene therapy, uniQure develops transformative treatments using its AAV-based technology platform.
AtMoves
Improving orthopedic diagnostics with advanced joint loading device and AI-based imaging technology.
Explore full AAV portfolio
Contact